Pentavalent Antimonials Combined with Other Therapeutic Alternatives for the Treatment of Cutaneous and Mucocutaneous Leishmaniasis: A Systematic Review
The first choice drugs for the treatment of cutaneous and mucocutaneous leishmaniasis are pentavalent antimonials, sodium stibogluconate, or meglumine antimoniate. However, the treatment with these drugs is expensive, can cause serious adverse effects, and is not always effective. The combination of...
Saved in:
Main Authors: | Taisa Rocha Navasconi Berbert, Tatiane França Perles de Mello, Priscila Wolf Nassif, Camila Alves Mota, Aline Verzignassi Silveira, Giovana Chiqueto Duarte, Izabel Galhardo Demarchi, Sandra Mara Alessi Aristides, Maria Valdrinez Campana Lonardoni, Jorge Juarez Vieira Teixeira, Thaís Gomes Verziganassi Silveira |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Dermatology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2018/9014726 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Screening of six medicinal plant species for antileishmanial activity
by: Ferreira Fabiana Borges Padilha, et al.
Published: (2021-09-01) -
Pentavalent Vaccine‐Induced Immune Thrombocytopenia: A Case Report From Nepal
by: Ramesh Khadayat, et al.
Published: (2025-01-01) -
Applications of Antimony in Catalysis
by: Lewen Wu, et al.
Published: (2024-11-01) -
Is It Stevens–Johnson Syndrome or MIS-C with Mucocutaneous Involvement?
by: Abdollah Karimi, et al.
Published: (2021-01-01) -
Bioaccumulation of Antimony and Arsenic in Vegetables and Health Risk Assessment in the Superlarge Antimony-Mining Area, China
by: Defang Zeng, et al.
Published: (2015-01-01)